On September 8, 2026, 招银国际金融控股有限公司 sold 1.22 million shares of BIOCYTOGEN-B (02315) at an average of HKD 62.2724 per share, involving about HKD 76.03 million.

Prior to the disposal, 招银国际金融控股有限公司's long position in BIOCYTOGEN-B was 10.98 million shares, representing 9.91%; following the disposal, the holding changed to 9.76 million shares, with the long position ratio falling to 8.81%.

Source: Hong Kong Exchanges and Clearing Limited.